Saxenda is a brand-name injectable prescription medication containing liraglutide, a GLP-1 receptor agonist FDA-approved specifically for chronic weight management in adults and teens 12 and older. It is the weight-loss version of the same active ingredient used in the diabetes drug Victoza.
Clinical trials show 85% of adult patients taking Saxenda lost some weight over 56 weeks. Three out of five achieved weight loss of 5% or more, and one in three lost more than 10% of body weight. Saxenda reduces waist circumference by 3.2 inches (8.1 cm) versus 1.6 inches (4.1 cm) with placebo. Side effects are primarily gastrointestinal, and the drug carries a black box warning for thyroid C-cell tumors.
This review covers how Saxenda works, what the clinical trial results actually show, who qualifies for treatment, how it compares to newer GLP-1 alternatives, and what the real-world weight loss numbers look like.
What Is Saxenda?
Saxenda is a brand-name injectable prescription medication containing liraglutide 3.0 mg, FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related health condition. It is manufactured by Novo Nordisk, the same company that makes Victoza.
Saxenda is not a diabetes drug. It targets weight management as the primary indication. The FDA approved it for adults with a BMI of 30 kg/m2 (66 lb/m2) or greater, or a BMI of 27 kg/m2 (59.5 lb/m2) or greater with at least one comorbidity like hypertension, type 2 diabetes, or dyslipidemia.
Saxenda is not interchangeable with Victoza. Both contain liraglutide, but at different doses for different purposes. The two must never be used together, as this creates a risk of liraglutide overdose and significantly increased side effects.
Is Saxenda FDA-Approved for Weight Loss?
Yes. Saxenda is specifically FDA-approved for chronic weight management in adults and in teens 12 years and older who weigh at least 132 lbs (60 kg) and meet BMI thresholds for their age and sex.
The teen approval was added in 2020. This makes Saxenda one of the few GLP-1 medications approved for adolescent weight management. The qualifying criteria for teens are adjusted BMI thresholds relative to age and sex percentiles rather than the fixed adult thresholds.
Who Can Take Saxenda?
Adults qualify for Saxenda with a BMI of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol.
Teens 12 and older who weigh at least 132 lbs (60 kg) may qualify based on age-specific BMI standards. Saxenda cannot be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It also must not be used with insulin.
How Does Saxenda Work for Weight Loss?
Saxenda activates GLP-1 receptors in the brain and gut to regulate appetite, slow gastric emptying, and reduce caloric intake — producing clinically meaningful weight loss when combined with a reduced-calorie diet and increased physical activity.
The mechanism targets the body’s natural appetite regulation system. GLP-1 is a hormone the gut releases after eating. Saxenda mimics this hormone at a sustained level, keeping satiety signals active throughout the day rather than just after meals.
Gastric emptying slows significantly under Saxenda’s effect. Food stays in the stomach longer, delaying nutrient absorption and prolonging the sensation of fullness. This reduces total daily caloric intake without requiring willpower-intensive restriction.
What Does GLP-1 Do for Appetite?
GLP-1 is a natural gut hormone that signals the hypothalamus to reduce hunger, signals the pancreas to release insulin, and slows gastric emptying — all three actions contributing to reduced food intake and lower post-meal blood sugar spikes.
Saxenda maintains elevated GLP-1 receptor activity between meals, not just after eating. This sustained activation suppresses hunger signals in the brain throughout the day, reducing the drive to snack or overeat at the next meal.
How Long Does Saxenda Take to Work?
Saxenda begins reducing appetite within the first week of treatment, though the initiation dose of 0.6 mg is too low for significant weight loss — that begins after reaching therapeutic doses at weeks 2-5 of the titration schedule.
Clinical trials show weight loss continues progressively through 56 weeks. A recent Obesity Facts study found liraglutide can help people lose nearly 10% of body weight within four months. The speed of loss depends on starting weight, other medical conditions, stress level, and activity level.
What Are the Results of Saxenda Clinical Trials?
Saxenda produced statistically significant weight loss versus placebo across three major 56-week clinical studies, with 85% of adult patients losing some weight and the majority achieving clinically meaningful loss of 5% or more of baseline body weight.
The primary trial enrolled 3,731 adults without type 2 diabetes with a BMI of 30 kg/m2 or greater. All participants received a reduced-calorie diet (~500 kcal/day deficit) and physical activity counseling. Saxenda’s results are established alongside lifestyle modification, not as a standalone treatment.
Saxenda also reduced waist circumference by 3.2 inches (8.1 cm) versus 1.6 inches (4.1 cm) with placebo in the primary trial. Mean baseline waist circumference was 45.3 inches (115 cm) for Saxenda patients, making this a clinically meaningful absolute reduction.
Saxenda Adult Trial Results at 56 Weeks:
| Outcome | Saxenda | Placebo |
|---|---|---|
| Lost any weight | 85% | Significantly lower |
| Lost 5% or more of body weight | 60% | Lower |
| Lost 10% or more of body weight | 33% | Lower |
| Lost 20% or more of body weight | 6% | Lower |
| Waist circumference reduction | 3.2 inches (8.1 cm) | 1.6 inches (4.1 cm) |
How Much Weight Can You Lose on Saxenda?
Patients who achieved 5% or more weight loss on Saxenda lost an average of approximately 12 lbs (5.4 kg) from study entry, while those who lost 10% or more lost an average of approximately 23 lbs (10.4 kg).
Individual results vary widely. Average weight loss in clinical studies was 5-10% of body weight over 36 months per JAMA and NEJM studies. Patients at higher baseline BMI tend to lose larger absolute amounts. Pairing Saxenda with a structured behavior change program produces the best outcomes.
Can You Keep the Weight Off on Saxenda?
Weight maintenance on Saxenda is demonstrated in Study 3, where patients who had already lost at least 5% of body weight through lifestyle changes maintained that loss significantly better with Saxenda than with placebo over 56 weeks.
Weight regain after stopping treatment is well-documented in GLP-1 research. The body’s weight regulatory systems re-engage once the medication is withdrawn. Long-term or indefinite use is typically required to sustain the weight loss effects of Saxenda and similar GLP-1 medications.
What Are the Side Effects of Saxenda?
Saxenda most commonly causes nausea, vomiting, diarrhea, constipation, and hypoglycemia, with gastrointestinal effects most prominent during dose escalation and typically decreasing as the body adjusts to the medication.
The good news? The dose titration protocol minimizes GI side effects. Starting at 0.6 mg/day and increasing weekly reduces the severity of nausea and vomiting during initiation. Eating smaller meals, avoiding high-fat foods, and staying upright after eating all help manage initial nausea.
Here’s what you need to watch: Saxenda carries a black box warning for thyroid C-cell tumors (medullary thyroid carcinoma, or MTC). This warning is based on animal studies. Patients with a personal or family history of MTC or MEN 2 must not use Saxenda under any circumstances.
Common Saxenda Side Effects:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Low blood sugar (hypoglycemia)
- Decreased appetite
- Injection site reactions
Is Saxenda Safe?
Yes. Saxenda is FDA-approved and clinically validated as safe for eligible patients who do not have a history of MTC or MEN 2, do not use insulin, and do not take other GLP-1 receptor agonists concurrently.
Pancreatitis risk requires monitoring throughout treatment. Patients should report persistent severe abdominal pain immediately. Saxenda also affects gallbladder function; gallstones have been reported in clinical trials. Ongoing medical supervision is required for safe long-term use.
How Do You Take Saxenda?
Saxenda is administered as a once-daily subcutaneous injection using a pre-filled pen, injected into the abdomen, thigh, or upper arm at any consistent time of day, with or without food.
The pen delivers doses from 0.6 mg to 3.0 mg per day. Saxenda follows a weekly titration schedule starting at 0.6 mg and increasing in 0.6 mg increments each week. Pairing Saxenda with a reduced-calorie diet (~500 kcal/day deficit) and increased physical activity is required for optimal results.
What Is the Starting Dose of Saxenda?
The recommended starting dose is 0.6 mg once daily for week 1, increasing weekly by 0.6 mg increments until reaching the full therapeutic dose of 3.0 mg daily by week 5 of treatment.
Saxenda Dose Escalation Schedule:
| Week | Daily Dose |
|---|---|
| Week 1 | 0.6 mg |
| Week 2 | 1.2 mg |
| Week 3 | 1.8 mg |
| Week 4 | 2.4 mg |
| Week 5 onward | 3.0 mg (full dose) |
Saxenda vs. Other GLP-1 Medications: How Does It Compare?
Saxenda uses liraglutide at 3.0 mg/day for weight management, while newer GLP-1 agents like Wegovy (semaglutide 2.4 mg weekly) and Zepbound (tirzepatide) produce greater average weight loss in head-to-head data and real-world use.
By comparison, Wegovy produces average weight loss of approximately 15% of body weight versus Saxenda’s clinical average of 5-10%. Tirzepatide (Zepbound/Mounjaro) shows the highest average weight loss of any approved GLP-1 class medication in current trials, reaching 20%+ in some studies.
Saxenda does hold advantages in certain contexts. It has a longer safety record than newer agents. It is approved for teens 12 and older, where newer agents are not. The daily injection format offers dose-level flexibility that weekly injections cannot match during titration.
GLP-1 Weight Loss Medication Comparison:
| Drug | Active Ingredient | Frequency | Avg. Weight Loss |
|---|---|---|---|
| Saxenda | Liraglutide 3.0 mg | Daily | 5-10% |
| Wegovy | Semaglutide 2.4 mg | Weekly | ~15% |
| Zepbound | Tirzepatide | Weekly | ~20% |
| Victoza | Liraglutide 1.8 mg | Daily | 3-5% (off-label) |
How Much Does Saxenda Cost?
Saxenda is an expensive brand-name biologic medication with a retail cost that can exceed 1,000 dollars per month without insurance coverage, making cost one of the most significant barriers to access for eligible patients.
Novo Nordisk offers SaxendaCare savings programs that may reduce out-of-pocket costs for commercially insured patients. Telehealth platforms specializing in weight management often provide prescription and ongoing care at lower total costs than traditional specialist visits. Pharmacy discount programs may also reduce costs at the point of purchase.
Is Saxenda Covered by Insurance?
Saxenda coverage varies widely by insurance plan; some plans cover it for qualifying patients, others exclude weight management medications entirely or require prior authorization and documentation of failed lifestyle interventions.
Medicare and Medicaid coverage for Saxenda is limited and inconsistent across states. Private insurance coverage often requires a documented BMI threshold and comorbidities. Patients should contact their insurer directly to confirm whether Saxenda is on their formulary before starting treatment.
Should You Try Eat Proteins for Weight Support?
Saxenda works best alongside a reduced-calorie diet and structured physical activity — and Eat Proteins provides the expert nutrition coaching and accountability framework that turns medication-assisted weight loss into lasting lifestyle change.
Here’s the thing: clinical trials require a 500 kcal/day deficit diet alongside Saxenda for the results to hold. Most patients can’t build that structure alone. Our coaches at Eat Proteins design the nutritional frameworks that maximize GLP-1 medication outcomes in the real world.
Don’t rely on medication alone. The patients who keep weight off long-term combine pharmacological support with genuine habit change. Eat Proteins gives you both. Start today and build the foundation that makes your Saxenda results permanent.